Bridgeway Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32,350	Closed	-$3.7M	–	1420
2023 Q2	$3.7M	Buy	32,350 +2,750	+9%	+$315K	0.09%	364
2023 Q1	$4.08M	Hold	29,600	–	–	0.11%	320
2022 Q4	$3.84M	Buy	29,600 +13,800	+87%	+$1.79M	0.1%	341
2022 Q3	$1.75M	Buy	+15,800	New	+$1.75M	0.05%	569